RedHawk Pharma LLC is in negotiations to purchase undisclosed cannabis assets in Oklahoma.
The news was announced Friday by parent company RedHawk Holdings Corp. SNDD, a diversified holding company focused on sales and distribution of medical devices.
According to the press release, specific cannabis assets include licenses to grow, manufacture, and sell within the state.
The company stressed that the focus is on "craft" cultivation as well as the distribution of product.
The potential deal closing would take place before the year-end.
It is subject to the approval of RedHawk's board of directors as well as acceptance and approval by the seller's board of directors and shareholders, among others.
The Lafayette, Louisiana-based company is also engaged in sales of branded generic pharmaceutical drugs, while it has its fair share in commercial real estate investment as well.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.